/cloudfront-us-east-2.images.arcpublishing.com/reuters/BSYGKPNE5ZPRXH2OTG23T4DSYI.jpg?resize=400%2C240&ssl=1 "US FDA authorizes Novavax’s updated COVID shot, shares rise")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/BSYGKPNE5ZPRXH2OTG23T4DSYI.jpg?resize=80%2C80&ssl=1 "US FDA authorizes Novavax’s updated COVID shot, shares rise")
A vial labelled “Novavax COVID-19 Vaccine” is seen in this illustration taken January 16, 2022. REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing Rights Oct 3 (Reuters) – The...
/cloudfront-us-east-2.images.arcpublishing.com/reuters/2LRZZMHL7JPZRCWWMCOF47OYZI.jpg?resize=400%2C240&ssl=1 "WHO recommends malaria vaccine that will be rolled out next year")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/2LRZZMHL7JPZRCWWMCOF47OYZI.jpg?resize=80%2C80&ssl=1 "WHO recommends malaria vaccine that will be rolled out next year")
A nurse fills a syringe with malaria vaccine before administering it to an infant at the Lumumba Sub-County hospital in Kisumu, Kenya, July 1, 2022. REUTERS/Baz...
CHICAGO, Sept 29 (Reuters) – The U.S. government said on Friday that a decision by France to vaccinate ducks against avian flu will trigger restrictions on...
/cloudfront-us-east-2.images.arcpublishing.com/reuters/ZKS7OXUCFZOGZI3ROI3QUVLBQU.jpg?resize=400%2C240&ssl=1 "GSK lifts growth target for HIV business on demand for long-acting drug")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/ZKS7OXUCFZOGZI3ROI3QUVLBQU.jpg?resize=80%2C80&ssl=1 "GSK lifts growth target for HIV business on demand for long-acting drug")
GSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration/File photo Acquire Licensing Rights Sept 28 – GSK (GSK.L) on Thursday lifted its...
/cloudfront-us-east-2.images.arcpublishing.com/reuters/IXYUV47KYRP5DGR3BXFFW4NLJE.jpg?resize=400%2C240&ssl=1 "US FDA declines to approve first nasal spray equivalent of EpiPen")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/IXYUV47KYRP5DGR3BXFFW4NLJE.jpg?resize=80%2C80&ssl=1 "US FDA declines to approve first nasal spray equivalent of EpiPen")
Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo Acquire Licensing Rights...
Sept 15 (Reuters) – The U.S. National Institutes of Health (NIH) said on Friday that it has begun an early-stage study on its vaccine targeting...
Recent Comments